文献速递关节外科

抗生素管理干预改善全关节置换术中对青霉素过敏患者的预防性抗生素选择

Antibiotic Stewardship Interventions Improve Choice of Antibiotic Prophylaxis in Total Joint Arthroplasty in Patients with Reported Penicillin Allergies.
PubMed 文献 · Clin Orthop Relat Res · 2021-01-01

该单中心回顾性研究纳入180例报告青霉素过敏的初次全关节置换术患者,比较干预前后预防性抗生素使用的合理性。干预后合理使用率从54%升至91%,非严重过敏患者中从47%升至96%,未观察到头孢唑林相关过敏反应。

要点

  • 抗生素管理干预可显著提高青霉素过敏患者全关节置换术中头孢唑林等一线预防抗生素的合理使用率。
  • 非严重青霉素过敏患者(包括报告荨麻疹或局部肿胀者)可耐受头孢唑林。
  • 本研究中未观察到与头孢唑林相关的过敏反应,包括8例严重青霉素过敏患者。

核心结论

  • 多方面的抗生素管理干预提高了择期初次全关节置换术中预防性抗生素使用的合理性。
  • 报告非严重青霉素过敏的患者,即使有荨麻疹或局部肿胀,也能耐受头孢唑林。
  • 抗生素管理干预可在各机构实施,以扩大骨科全关节置换术患者中头孢菌素的使用。

研究设计与样本

  • 单中心回顾性研究,纳入261张床位的社区医院中年龄大于18岁、因初次择期全关节置换术就诊的骨科患者。
  • 研究分为干预前阶段(2017年3月1日至2017年8月30日)和干预后阶段(2019年3月1日至2019年8月30日)。
  • 共有396例有记录青霉素过敏史的患者在研究期间接受全髋或全膝关节置换术。
  • 每第四例符合纳入标准的青霉素过敏患者被审查,排除合并记录头孢菌素过敏者后,共评估180例有记录青霉素过敏的患者(干预前组90例,干预后组90例)。

主要发现

  • 干预后抗生素使用更合理(91% [82/90] 对比 54% [49/90],风险比1.67 [95%置信区间1.37至2.04];p < 0.01)。
  • 在非严重过敏患者中,干预前合理率为47%(36/76),干预后为96%(76/79);p < 0.01。
  • 没有患者出现与头孢唑林相关的过敏反应迹象,包括8例严重青霉素过敏患者。

临床怎么用

  • 对于报告青霉素过敏的择期初次全关节置换术患者,可实施抗生素管理干预以促进头孢唑林等一线预防抗生素的合理使用。
  • 非严重青霉素过敏(包括荨麻疹或局部肿胀)并非头孢唑林使用的禁忌,可考虑使用头孢唑林进行预防。

局限性

  • 本研究为单中心回顾性研究,证据等级为III级(治疗性研究)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most patients who report a penicillin allergy can tolerate cefazolin, the preferred prophylaxis in a total joint arthroplasty (TJA). Regardless, patients with a reported penicillin allergy are less likely to receive first-line perioperative antibiotics as a result of inaccurate penicillin allergy documentation and misconceptions regarding cross-reactivity between penicillin and cephalosporins. The over-reporting of penicillin allergies and the safety of cephalosporins in patients with reported penicillin allergies have been well established throughout the evidence [13]. QUESTIONS/PURPOSES: The study sought to answer two questions: (1) Do antibiotic stewardship interventions improve adherence to appropriate prophylactic antibiotic usage in patients with a documented penicillin allergy undergoing primary TJA? (2) What is the risk of allergic or adverse reactions secondary to cefazolin use in patients with a documented penicillin allergy? METHODS: This was a single-center, retrospective study of orthopaedic patients older than 18 years who underwent a primary elective TJA at a 261-bed community hospital. The study had two periods: the preintervention period ran from March 1, 2017 to August 30, 2017 and the postintervention period was from March 1, 2019 to August 30, 2019. A total of 396 patients with a history of a documented penicillin allergy underwent a THA or TKA during the study periods. After reviewing every fourth patient with a history of a documented penicillin allergy who met study inclusion criteria and excluding those patients who had a codocumented cephalosporin allergy, a total of 180 patients with a documented penicillin allergy were evaluated (90 patients in the preintervention group and 90 patients in the postintervention group). To answer our first study question, regarding whether antibiotic stewardship interventions improve adherence to appropriate prophylactic antibiotic usage in patients with a documented penicillin allergy undergoing primary TJA, we evaluated appropriate antibiotic usage pre- and postintervention. To answer our second study question, concerning the risk of allergic or adverse reactions secondary to cefazolin use in patients with a documented penicillin allergy, we reviewed signs of allergic reactions in patients who received cefazolin for a primary TJA and had a documented penicillin allergy. RESULTS: Postintervention antibiotic use was more appropriate (91% [82 of 90] versus 54% [49 of 90], risk ratio 1.67 [95% confidence interval 1.37 to 2.04]; p < 0.01), particularly in patients with nonsevere allergy (preintervention: 47% [36 of 76] versus postintervention: 96% [76 of 79]; p < 0.01). No patients had signs of an allergic reaction related to cefazolin, including eight patients with severe penicillin allergy. CONCLUSION: A multifaceted antibiotic stewardship intervention increased the appropriateness of antibiotic prophylaxis in elective primary TJA. Patients with nonsevere penicillin allergies, even those reporting hives or local swelling, tolerated cefazolin. Antibiotic stewardship interventions can be implemented across institutions to expand cephalosporin use in patients with a reported penicillin allergy within orthopaedic TJA patients. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Jones R, Quartuccio KS, Stern JL, et al. Antibiotic Stewardship Interventions Improve Choice of Antibiotic Prophylaxis in Total Joint Arthroplasty in Patients with Reported Penicillin Allergies. Clin Orthop Relat Res. 2021. PMID: 33856366. doi:10.1097/CORR.0000000000001739

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。